Clinical Research Programs
NJU physicians are engaged in a variety of clinical research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases. We are proud of the leadership role our doctors take in helping to prove the safety and efficacy of new treatments, and the opportunity it gives us to make those options available to our patients. Those potential advantages, however, are always considered in the context of the overall health and well-being of our patients.
Our clinical research department has a dedicated research staff who will assist you through your entire journey. Our state-of-the-art facilities offer a locked storage area for all trial-specific documentation and Investigational Product (IP), -70°F freezers to store specimens and IP, electrocardiogram (ECG) machines, refrigerated centrifuges for precise temperature management and sample protection, and pharmacokinetics (PK) capabilities.
If you think you may be eligible for and interested in participating in a clinical research program, your NJU urologist will discuss the potential benefits and risks with you so that you and your family can make an informed decision.
VIDEO SERIES | CLINICAL RESEARCH
New Jersey Urology (NJU) physicians are engaged in a variety of research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases.
NJU’s Senior Vice President of Clinical Research, Derek Grimes, is interviewed by UroGPO to discuss what makes clinical research a success in the field of urology.
EXPERIENCE
CLINICAL TRIALS | AT NJU
Prostate Cancer Immunotherapies
You may be eligible for New Jersey Urology’s immunotherapy clinical trials now available at our Saddle Brook and West Orange, New Jersey Cancer Treatment Centers.
What is Immunotherapy?
Immunotherapy teaches your body to spot and destroy cancer cells, and may help your immune system long after your treatment ends.
Types of Immunotherapy
Certain types of immunotherapy attack cancer while sparing healthy cells or slow its spread to other parts of the body.
Register now to see if you qualify or call 973-846-7028.
Sponsor / Study Title:
MANA RBM / ESCALATE, A Phase III Randomized Study Comparing Enzalutamide or Darolutamide with Radium-223 vs Enzalutamide or Darolutamide with Placebo and the Effect upon Symptomatic Skeletal Event-Free Survival for mCRPC Patients
Protocol Number:
Principal Investigator:
(Study Doctor)
Telephone:
Address:
PC18-1005
Domenico Savatta, MD, FACS
908-484-6575
New Jersey Urology
1515 Broad Street, Suite 120
Bloomfield, NJ 07003
You may be eligible for a Phase 3 Prostate Cancer Clinical Trial for metastatic castration-resistant prostate cancer (mCRPC) that may help to stop or prevent the cancer from spreading to your bones. For more information, call us at 908.484.6575.
KEY INFORMATION
You are invited to take part in a research study. This research study is studying Xtandi (enzalutamide) or Nubeqa (darolutamide) followed by Xofigo (radium-223) or Placebo (saltwater) as a possible treatment for metastatic castration-resistant prostate cancer (mCRPC). MANA RBM is sponsoring this research study. The Informed Consent provides a summary of this research. It describes the important information that we believe most people need in order to decide whether to take part in this research.
Sponsor / Study Title:
Urovant Sciences GmbH / Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Protocol Number:
Principal Investigator:
(Study Doctor)
Telephone:
Address:
URO-901-3005
Eric J. Margolis, MD
(833) 876-8268
New Jersey Urology
1515 Broad Street, Suite 120
Bloomfield, NJ 07003
About the COURAGE Study
A clinical research study is testing the safety and effectiveness of an investigational drug in men on BPH therapy experiencing OAB symptoms. The investigational drug, vibegron, is compared with a placebo. A placebo looks exactly like the investigational drug but contains no active medication. Over 1000 participants in approximately 135 study centers across North America and Europe are expected to take part in the COURAGE Study.
LOCATIONS
To make an appointment with an NJU physician with expertise in Clinical Research, please call one of the phone numbers listed below.
Bloomfield
1515 Broad Street
Suite 120
Bloomfield, NJ 07003
Phone: (973) 873-7000
Cherry Hill
2090 Springdale Road
Suite B
Cherry Hill, NJ 08003
Phone: (856) 751-9010
Cranford
570 South Avenue East
Building A
Cranford, NJ 07106
Phone: (908) 603-4201
Lawrenceville
3311 Brunswick Pike
Lawrenceville, NJ 08648
P: 609.716.7030
Phone: (609) 716-7030
Saddle Brook
160 Pehle Avenue
Suite 103
Saddle Brook, NJ 07663
Phone: (201) 881-1000
West Orange
375 Mount Pleasant Avenue
Suite 251
West Orange, NJ 07052
Phone: (973) 323-1300
Mount Laurel
15000 Midlantic Drive, Suite 100
Mount Laurel, NJ 08054
Phone: (856) 840-4563
Voorhees
2401 Evesham Road, Suite F
Voorhees, NJ 08043
Phone: (856) 673-1613